Vote Scores
Filings read through

Roivant Sciences Ltd.: how funds voted at the meeting of 10 Sep 2024

Ticker
ROIV
Meeting
Season
year to 30 June 2025
Filers reporting
368
Ballot items
4

368 filers on Form N-PX reported votes at the Roivant Sciences Ltd. meeting of 10 Sep 2024. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Roivant Sciences Ltd. has the latest meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2025. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    3 nominees. 64.6% of the reported votes are for. 76 filers withheld from or voted against at least one nominee.

    774 vote records from 124 filers. 46 of the 122 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 36 fund families
    • For 23
    • Abstain or withhold 13
    • Against management 13
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    565 vote records from 363 filers. 85 of the 345 filers that marked the item voted against management. 18 filers gave no management mark.

    • Positions of 41 fund families
    • For 32
    • Against 9
    • Against management 9
  3. Item 3: Frequency of the say-on-pay vote

    1: 4 filers. One year: 320 filers. Abstain: 6 filers. Three years: 5 filers. For: 5 filers. 1-year: 2 filers.

    565 vote records from 363 filers. 11 of the 342 filers that marked the item voted against management. 21 filers gave no management mark.

    • Positions of 41 fund families
    • Split or no vote 41
  4. Item 4: Audit-related items (auditor ratification)

    257 vote records from 123 filers. 2 of the 121 filers that marked the item voted against management. 2 filers gave no management mark.

    • Positions of 36 fund families
    • For 36

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Roivant Sciences Ltd., meeting of 10 Sep 2024Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
AllianceBernsteinAgainst, against managementSplitNo report
AllspringForSplitNo report
American CenturyAgainst, against managementSplitFor
BlackRock and iSharesForSplitFor
BNY MellonForSplitFor
Brighthouse FundsForSplitFor
Charles SchwabForSplitFor
Columbia ThreadneedleForSplitFor
EquitableForSplitFor
Federated HermesForSplitFor
FidelityAgainst, against managementSplitFor
First TrustForSplitFor
Franklin TempletonForSplitFor
Global XAgainst, against managementSplitFor
Goldman SachsForSplitFor
Guggenheim and RydexForSplitFor
InvescoForSplitFor
J.P. MorganAgainst, against managementSplitFor
Jackson National fundsForSplitFor
Janus HendersonForSplitNo report
John Hancock and ManulifeForSplitFor
Lincoln FinancialForSplitFor
Macquarie and Delaware FundsForSplitFor
Morgan Stanley, Eaton Vance and CalvertForSplitFor
NationwideForSplitFor
Natixis and Loomis SaylesAgainst, against managementSplitFor
Neuberger BermanAgainst, against managementSplitNo report
Northern Trust and FlexSharesForSplitFor
Nuveen and TIAAForSplitFor
Pacific Life fundsForSplitFor
PGIM and PrudentialAgainst, against managementSplitFor
PrincipalForSplitFor
ProShares and ProFundsForSplitFor
SEIAgainst, against managementSplitFor
State Street and SPDRForSplitFor
T. Rowe PriceForSplitFor
ThriventForSplitFor
TransamericaForSplitFor
VanguardForSplitFor
Victory CapitalForSplitNo report
VoyaForSplitFor

Questions

How many filers reported votes at the Roivant Sciences Ltd. meeting?
368 Form N-PX filers reported votes at the meeting of 10 Sep 2024. On say-on-pay, 85 of 345 filers that marked the item voted against management (24.6%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Roivant Sciences Ltd. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Roivant Sciences Ltd. with a meeting date within three days of 10 Sep 2024. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .